Routine screening of blood donations at Qingdao central blood bank, China, for hepatitis B virus (HBV) DNA with a real-time, multiplex nucleic acid test for HBV, hepatitis C virus, and human immunodeficiency virus Types 1 and 2

Transfusion

Volumn 53, Issue 10 PART 2, 2013, Pages 2538-2544

  Yang, Zhongsi ^a,b   Xu, Lei ^a,b   Liu, Li ^a,b   Feng, Qiuxia ^a,b   Zhang, Longmu ^a,b   Ma, Weijuan ^a,b   Saldanha, John ^a,b   Wang, Mingmin ^a,b   Zhao, Lin ^a,b  

^a Qingdao Blood Center   (China)

^b ROCHE MOLECULAR SYSTEMS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS DNA;

ADULT; ARTICLE; BLOOD; BLOOD BANK; BLOOD DONOR; CHINA; GENETICS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; ISOLATION AND PURIFICATION; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; SEROLOGY; STATISTICS; YOUNG ADULT; HEPACIVIRUS; PROCEDURES; STATISTICS AND NUMERICAL DATA;

ADULT; BLOOD BANKS; BLOOD DONORS; CHINA; DNA, VIRAL; HEPACIVIRUS; HEPATITIS ANTIBODIES; HEPATITIS B VIRUS; HIV ANTIBODIES; HIV-1; HIV-2; HUMANS; MASS SCREENING; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; REAL-TIME POLYMERASE CHAIN REACTION; SEROLOGIC TESTS; YOUNG ADULT;

EID: 84891701995     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12159     Document Type: Article

References (25)

1. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Wang F, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009;27:6550-7.
2. Roth WK, Busch MP, Schuller A, Ismay S, Cheng A, Seed CR, Jungbauer C, Minsk PM, Sondag-Thull D, Wendel S, Levi JE, Fearon M, Delage G, Xie Y, Jukic I, Turek P, Ullum H, Tefanova V, Tilk M, Reimal R, Castren J, Naukkarinen M, Assal A, Jork C, Reesink HW et al. International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang 2012;102:82-90.
3. Shang G, Yan Y, Yang B, Shao C, Wanga F, Li Q, Seed CR. Two HBV DNA+/HBsAg blood donors identified by HBV NAT in Shenzhen, China. Transfus Apher Sci 2009;41:3-7.
4. Ren R, Wang JX, Huang Y, Yao FZ, Lv YL, Li JL, Wen GX, Wen XQ, Liu J, Dong XD, Ma HL, Zhou ZM, Bi XH, Tu L, King M, Nelson K, Ness P, Shan H. Hepatitis B virus nucleic acid testing in Chinese blood donors with normal and elevated alanine aminotransferase. Transfusion 2011;51: 2588-95.
5. Roche Diagnostics. IFU cobas TaqScreen MPX Test for use on the cobas s 201 system. Branchburg (NJ): Roche Diagnostics; 2010.
6. Roche Diagnostics. IFU COBAS AmpliPrep/COBAS TaqMan HBV Test for in vitro diagnostic use. Branchburg (NJ): Roche Diagnostics; 2005.
7. Roche Diagnostics. IFU COBAS AmpliPrep/COBAS TaqMan HBV Test, v2.0, for in vitro diagnostic use. Branchburg (NJ): Roche Diagnostics; 2010.
8. Zhang R, Wang L, Li J. Hepatitis B transfusion risk in China: proficiency testing for the detection of hepatitis B surface antigen. Transfus Med 2010;20:322-8.
9. Roche Diagnostics. IFU cobas ECLIA HBsAg Test. Branchburg (NJ): Roche Diagnostics; 2010.
10. Heermann KH, Gerlich WH, Chudy M, Schaefer S, Thomssen R; the Eurohep Pathobiology Group. Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations. J Clin Microbiol 1999;37:68-73
11. Li L, Chen PJ, Chen MH, Chak KF, Lin KS, Lin Tsai SJ. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infection and closing the serologic window for hepatitis C virus. Transfusion 2008;48:1198-206.
12. Louisirirotchanakul S, Oota S Khuponsarb K, Chalermchan W, Soisaang P, Chongkolwatana V, Sakuldamrongpanish T, Kitpoka P, Chielsilp P, Tanprasert S, Tirawatnapong T, Wasi C; theWorking Group for NAT Study in Thai Blood Donations. Occult hepatitis B virus infection in Thai blood donors. Transfusion 2011;51:1532-40.
13. Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol 2007;46:160-70.
14. Allain JP. Occult hepatitis B virus infection: implications in transfusion. Vox Sang 2004;86:83-91.
15. Hollinger FB. Hepatitis B virus infection and transfusion medicine: science and the occult. Transfusion 2008;48: 1001-26.
16. Charlewood R, Flanagan P. Ultrio and Ultrio Plus nondiscriminating reactives: false reactives or not? Vox Sang 2013;104:7-11.
17. Dettori S, Candido A, Kondili LA, Chionne P, Taffon S, Genovese D, Iudicone P, Miceli M, Rapicetta M. Identification of low HBV-DNA levels by nucleic acid amplification test (NAT) in blood donors. J Infect 2009;59:128-33.
18. Brojer E, Grabarczyk P, Liszewski G, Mikulska M, Allain JP, Letowska M; the Polish Blood Transfusion Service Viral Study Group. Characterization of HBV DNA/HBsAg blood donors in Poland identified by triplex NAT. Hepatology 2006;44:1666-74.
19. Zou S, Dorsey KA, Notari EP. Foster GA, Krysztof DE, Musavi F, Dodd RY, Stramer SL. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion 2010;50:1495-504.
20. Nübling CM, Heiden M, Chudy M, Kress J, Seitz R, Keller-Stanislawski B, Funk MB. Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions. Transfusion 2009;49:1850-8.
21. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology 2001;34:194-203.
22. Allain JP, Hewitt PE, Tedder RS, Williamson LM. Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion. Br J Haematol 1999;107: 186-95.
23. Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, Tadokoro K. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Transfusion 2007;47:1197-205.
24. Levicnik-Stezinar S, Rahne-Potokar U, Candotti D, Lelie N, Allain JP. Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol 2008;48:1022-5.
25. Taira R, Satake M, Momose S, Hino S, Suzuki Y, Murokawa H, Uchida S, Tadokoro K. Residual risk of transfusiontransmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan. Transfusion 2013;53:1393-404.